A new fluorescent-avidin–based method for quantifying basophil activation in whole blood - 05/10/17
Doi : 10.1016/j.jaci.2017.03.052
Kaori Mukai, PhD a, b, R. Sharon Chinthrajah, MD b, c, Kari C. Nadeau, MD, PhD b, c, Mindy Tsai, DMSc a, b, Nicolas Gaudenzio, PhD a, b, d, ∗ 
, Stephen J. Galli, MD a, b, e, ∗
, Stephen J. Galli, MD a, b, e, ∗ a Department of Pathology, Stanford University School of Medicine, Stanford, Calif
b Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, Calif
c Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, Calif
d Unité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR), UMR 1056 Inserm - Université de Toulouse, Toulouse, France
e Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, Calif
| N.G. is supported by fellowships from the French “Fondation pour la Recherche Médicale FRM” (award no. SPE20130326582) and the Philippe Foundation. This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease (grant no. 5U19AI104209), a Seed Grant from the Stanford Institute of Immunity, Transplantation and Infection, and the Department of Pathology, Stanford University. |
|
| Disclosure of potential conflict of interest: K. Mukai has received a grant from the National Institute of Allergy and Infectious Diseases (grant no. 5U19AI104209) and has a patent planned through Stanford University. R. S. Chinthrajah has received a grant from the National Institute of Allergy and Infectious Diseases. M. Tsai has received a grant from the National Institutes of Health and has a patent planned through Stanford University. N. Gaudenzio has a patent planned through Stanford University. S. J. Galli has received grants from the National Institutes of Health (grant nos. 5U19AI104209 and R01AR067145), is a member of the National Institute of Allergy and Infectious Disease Advisory Council, and has a patent planned through Stanford University. |
© 2017
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 140 - N° 4
P. 1202 - octobre 2017 Retour au numéro
Article précédent
- Hematopoietic stem cell transplantation for RelB deficiency
- Adi Ovadia, Yael Dinur Schejter, Eyal Grunebaum, Vy Hong-Diep Kim, Brenda Reid, Tal Schechter, Elena Pope, Chaim M. Roifman
- Unique influenza A cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion
- Levi B. Watkin, Rabinarayan Mishra, Anna Gil, Nuray Aslan, Dario Ghersi, Katherine Luzuriaga, Liisa K. Selin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?